26.14BMarket Cap-79787P/E (TTM)
31.000High29.700Low3.56MVolume30.700Open30.650Pre Close108.01MTurnover0.41%Turnover Ratio33.19P/E (Static)871.47MShares35.90052wk High4.52P/B26.14BFloat Cap19.00052wk Low--Dividend TTM871.47MShs Float85.800Historical High--Dividend LFY4.24%Amplitude11.360Historical Low30.297Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
HUTCHMED Stock Forum
$Hutchmed (China) (HCM.US)$
$Intra-Cellular Therapies (ITCI.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$Hutchmed (China) (HCM.US)$ Phase 3
$Viracta Therapeutics (VIRX.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3 ...
According to the ac...
No comment yet